164 related articles for article (PubMed ID: 35815661)
61. [Rudolf-Virchow Prize 1999. Genetics of respiratory tract carcinomas: correlation of genotype and phenotype].
Petersen I
Verh Dtsch Ges Pathol; 1999; 83():195-204. PubMed ID: 10714210
[TBL] [Abstract][Full Text] [Related]
62. Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors.
Dorantes-Heredia R; Ruiz-Morales JM; Cano-García F
Transl Lung Cancer Res; 2016 Aug; 5(4):401-12. PubMed ID: 27652204
[TBL] [Abstract][Full Text] [Related]
63. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
64. Evaluation of role of Notch3 signaling pathway in human lung cancer cells.
Hassan WA; Yoshida R; Kudoh S; Motooka Y; Ito T
J Cancer Res Clin Oncol; 2016 May; 142(5):981-93. PubMed ID: 26838758
[TBL] [Abstract][Full Text] [Related]
65. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas.
Ordóñez NG
Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695
[TBL] [Abstract][Full Text] [Related]
66. p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung.
Wu M; Wang B; Gil J; Sabo E; Miller L; Gan L; Burstein DE
Am J Clin Pathol; 2003 May; 119(5):696-702. PubMed ID: 12760288
[TBL] [Abstract][Full Text] [Related]
67. Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.
Udagawa H; Umemura S; Murakami I; Mimaki S; Makinoshima H; Ishii G; Miyoshi T; Kirita K; Matsumoto S; Yoh K; Niho S; Tsuchihara K; Goto K
Lung Cancer; 2018 Dec; 126():182-188. PubMed ID: 30527185
[TBL] [Abstract][Full Text] [Related]
68. Inosine Monophosphate Dehydrogenase Dependence in a Subset of Small Cell Lung Cancers.
Huang F; Ni M; Chalishazar MD; Huffman KE; Kim J; Cai L; Shi X; Cai F; Zacharias LG; Ireland AS; Li K; Gu W; Kaushik AK; Liu X; Gazdar AF; Oliver TG; Minna JD; Hu Z; DeBerardinis RJ
Cell Metab; 2018 Sep; 28(3):369-382.e5. PubMed ID: 30043754
[TBL] [Abstract][Full Text] [Related]
69. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
Xie F; Zheng X; Mao X; Zhao R; Ye J; Zhang Y; Sun J
Ann Thorac Surg; 2019 Jul; 108(1):219-226. PubMed ID: 30885850
[TBL] [Abstract][Full Text] [Related]
70. Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.
Li R; Yang Z; Shao F; Cheng H; Wen Y; Sun S; Guo W; Li Z; Zhang F; Xue L; Bi N; Wang J; Sun Y; Li Y; Tan F; Xue Q; Gao S; Shi S; Gao Y; He J
Nat Commun; 2021 Jun; 12(1):3785. PubMed ID: 34145257
[TBL] [Abstract][Full Text] [Related]
71. Comparison of epidermal growth factor receptor mutation detection turnaround times and concordance among real-time polymerase chain reaction, high-throughput next-generation sequencing and the Biocartis Idylla™ platforms in non-small cell lung carcinomas.
Sharma S; Satapathy A; Aggarwal A; Dewan A; Jain E; Katara R; Kumar V; Pal R; Pandey S; Naidu MM; Kini L; Pradhan D; Mohanty SK
Pathol Res Pract; 2021 Apr; 220():153394. PubMed ID: 33706124
[TBL] [Abstract][Full Text] [Related]
72. Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.
Norkowski E; Ghigna MR; Lacroix L; Le Chevalier T; Fadel É; Dartevelle P; Dorfmuller P; Thomas de Montpréville V
J Thorac Oncol; 2013 Oct; 8(10):1265-71. PubMed ID: 24457237
[TBL] [Abstract][Full Text] [Related]
73. Epigenetic inactivation of laminin-5-encoding genes in lung cancers.
Sathyanarayana UG; Toyooka S; Padar A; Takahashi T; Brambilla E; Minna JD; Gazdar AF
Clin Cancer Res; 2003 Jul; 9(7):2665-72. PubMed ID: 12855645
[TBL] [Abstract][Full Text] [Related]
74. Repeatedly next-generation sequencing during treatment follow-up of patients with small cell lung cancer.
JiaXin Y; XiaoFeng C; PengFei C; Songchen Z; Ziling L
Medicine (Baltimore); 2023 Jun; 102(26):e34143. PubMed ID: 37390276
[TBL] [Abstract][Full Text] [Related]
75. Tracheal polypoid combined small cell lung cancer (C-SCLC): A case report.
Testori A; Ferraroli G; De Carlo C; Bossi P; Alloisio M; Mangiameli G
Thorac Cancer; 2021 Jul; 12(13):2035-2038. PubMed ID: 33990130
[TBL] [Abstract][Full Text] [Related]
76. ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation.
Alam SK; Wang L; Ren Y; Hernandez CE; Kosari F; Roden AC; Yang R; Hoeppner LH
Br J Cancer; 2020 Sep; 123(5):819-832. PubMed ID: 32499571
[TBL] [Abstract][Full Text] [Related]
77. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
78. LSD1 Inhibitor T-3775440 Inhibits SCLC Cell Proliferation by Disrupting LSD1 Interactions with SNAG Domain Proteins INSM1 and GFI1B.
Takagi S; Ishikawa Y; Mizutani A; Iwasaki S; Matsumoto S; Kamada Y; Nomura T; Nakamura K
Cancer Res; 2017 Sep; 77(17):4652-4662. PubMed ID: 28667074
[TBL] [Abstract][Full Text] [Related]
79. Insulinoma-associated protein 1 immunostaining for various types of neuroendocrine tumors on FNA smears.
Hou T; Gan Q; Joseph CT; Sun X; Gong Y
Cancer Cytopathol; 2020 Oct; 128(10):725-732. PubMed ID: 32573984
[TBL] [Abstract][Full Text] [Related]
80. Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer.
Coe BP; Lockwood WW; Girard L; Chari R; Macaulay C; Lam S; Gazdar AF; Minna JD; Lam WL
Br J Cancer; 2006 Jun; 94(12):1927-35. PubMed ID: 16705311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
